z-logo
open-access-imgOpen Access
Monoclonal Antibody Therapy does not Abrogate Rejection Risk in Renal Transplant Recipients
Author(s) -
Sanjeev Goswami,
Mehra Narinder
Publication year - 2013
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/conf.fimmu.2013.02.00825
Subject(s) - daclizumab , medicine , rituximab , monoclonal antibody , antibody , immunology , monoclonal antibody therapy , renal transplant , transplantation , tacrolimus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom